Surprisingly, scientists have now found that prostate cancer behaves more aggressively in men who have vitamin D deficiency. Expert Urologist, Dr. David Samadi has previously discussed on his YouTube channel, the impact Vitamin D has on sexual dysfunction and fighting cancerous tumors in the prostate.Leading scientists at Northwestern Medicine concluded that men who have prostate cancer in the so-called “low grade” stage can benefit enormously from treatment with vitamin D. Prostate tumors in the low grade stage grow quite slowly. The cancer seems to be less aggressive, which means that the tumors also less rapidly scatter in the body, that is less likely to form metastases. According to Dr. David Samadi, these findings give professionals food for thought.Patients in the low grade state are therefore usually treated with restraint. One first advises to an “active monitoring”. The cancer is observed until growth progresses or the patient desires further treatment. However, the use of vitamin D in therapy could be an improved chance for treating disease, especially with low-grade prostate cancer.
According to Dr. Samadi, Vitamin D reduces those tissue inflammations that trigger cancer. Clinical studies took 37 men diagnosed with low-grade prostate cancer who wanted to undergo prostatectomy and 60 days before surgery, gave them a daily dose of 4,000 International Units of Vitamin D.After treatment, studies of the cancerous tissue were performed, and doctors found that in many patients of the vitamin D group, the prostate tumors had regressed. Doctors say the daily dose of 4,000 IU is a relatively small amount, but apparently enough to reduce the cancer in many cases, and higher doses are quite possible.
Dr. David Samadi is a board-certified physician and expert in Urology and Robotic Surgery. He is also Chairman of Urology and Chief of Robotic Surgery at Lenox Hill Hospital. He has more than 20 years experience and is internationally renown for his SMART surgery technique, using the DaVinci system to perform a robotic prostatectomy.Dr. Samadi earned his undergraduate and medical degree from Stony Brook University, and completed his medical internship at Montefiore Hospital. He completed a urology residency at Albert Einstein Hospital and his oncology residency at Memorial Sloan Kettering Cancer Center.He’s been honored with numerous awards including Best Doctor, Top Doctor, and New York Metro Best Doctor, as well as the Connelly Award. Dr. David Samadi continues to perfect his techniques and teach students in robotic surgery for prostate and urologic diseases.